Development of a vaccine marker technology: Display of B cell epitopes on the surface of recombinant polyomavirus-like pentamers and capsoids induces peptide-specific antibodies in piglets after vaccination

Biotechnology Journal

Volumn 1, Issue 12, 2006, Pages 1435-1446

  Neugebauer, Markus ^a,b   Walders, Birgit ^a,b   Brinkman, Marc ^a,b   Ruehland, Claus ^b   Schumacher, Thomas ^b   Bertling, Wolf M ^a   Geuther, Eugen ^c   Reiser, Christian O A ^a,b   Reichel, Christoph ^b   Strich, Sandra ^a,b   Hess, Juergen ^a,b,d  

^a AG   (Germany)

^b Pharmacia GmbH   (Germany)

^c TRION Pharma ^*  (Germany)

^d TRION Pharma   (Germany)

Author keywords

Capsoid; Capsomer; Pentamer; Vaccine; Virus like particles

Indexed keywords

AGRICULTURE; ANTIBODIES; DISPLAY DEVICES; ESCHERICHIA COLI; PEPTIDES; RECOMBINANT PROTEINS; VACCINES; VIRUSES;

CAPSOID; CAPSOMER; EPITOPE SPECIFIC ANTIBODIES; HETEROLOGOUS EXPRESSION; HUMORAL IMMUNE RESPONSE; KEYHOLE LIMPET HEMOCYANINS; PENTAMERS; VIRUS-LIKE PARTICLES;

EPITOPES;

BIOLOGICAL MARKER; EPITOPE; PEPTIDE; VIRUS VACCINE;

ANIMAL; ARTICLE; BIOTECHNOLOGY; EPITOPE MAPPING; GENETICS; IMMUNOLOGY; METABOLISM; METHODOLOGY; POLYOMA VIRUS; SWINE; VACCINATION; VIRION; VIRUS CAPSID;

ANIMALS; BIOLOGICAL MARKERS; BIOTECHNOLOGY; CAPSID; EPITOPE MAPPING; EPITOPES, B-LYMPHOCYTE; PEPTIDES; POLYOMAVIRUS; SWINE; VACCINATION; VIRAL VACCINES; VIRION;

EID: 39049183787     PISSN: 18606768     EISSN: 18607314     Source Type: Journal    
DOI: 10.1002/biot.200600149     Document Type: Article

References (49)

1. Beyer, T., Herrmann, M., Reiser, C., Bertling, W., Hess, J., Bacterial carriers and virus-like-particles as antigen delivery devices: role of dendritic cells in antigen presentation. Curr. Drug Targets Infect. Disord. 2001, 1, 287-302.
2. Boisgerault, F., Moron, G., Leclerc, C., Virus-like particles: a new family of delivery systems. Expert Rev. Vaccines 2002, 1, 101-109.
3. Da Silva, D. M., Velders, M. P., Rudolf, M. P., Schiller J. T., Kast, W. M., Papillomavirus virus-like particles as anticancer vaccines. Curr. Opin. Mol. Ther. 1999, 1, 82-89.
4. Moron, G., Rueda, P., Casal, I., Leclerc, C., CD8〈 -CD11b+ dendritic cells present exogenous virus-like-particles to CD8+ T cells and subsequently express CD8〈 ?and CD205 molecules. J. Exp. Med. 2002, 10, 1233-1245.
5. Niikura, M., Takamura, S., Kim, G., Kawai, S. et al., Chimeric recombinant hepatitis E virus-like-particles as an oral vaccine vehicle presenting foreign epitopes. Virology 2002, 293, 273-280.
6. Schiller, J. T., Papillomavirus-like particle vaccines for cervical cancer. Mol. Med. Today 1999, 5, 209-215.
7. Blumberg, B. S., Hepatitis B virus, the vaccine, and the control of primary cancer in the liver. Proc. Natl. Acad. Sci. USA 1997, 94, 7121-7125.
8. Bonanni, P., Universal hepatitis B immunization: infant, and infant plus adolescent immunization. Vaccine 1998, 16 Suppl, S17-22.
9. Abbing, A., Blaschke, U. K., Grein, S., Kretschmar, M. et al., Efficient intracellular delivery of a protein and a low molecular weight substance via recombinant polyomavirus-like particles. J. Biol. Chem. 2004, 279, 27410-27421.
10. Brinkman, M., Walter, J., Jennes, I., Neugebauer, M. et al., Recombinant murine polyoma virus-like-particles induce protective anti-tumour immunity. Lett. Drug Des. Discov. 2004, 1, 137-147.
11. Brinkman, M., Walter, J., Grein, S., Thies, M. J. et al., Beneficial therapeutic effects with different particulate structures of murine polyomavirus VP1-coat protein carrying self or non-self CD8 T cell epitopes against murine melanoma. Cancer Immunol. Immunother. 2005, 54, 611-622.
12. Gleiter, S., Stubenrauch, K., Lilie, H., Changing the surface of a virus shell fusion of an enzyme to polyoma VP1. Protein Sci. 1999, 8, 2562-2569.
13. Gleiter, S., Lilie, H., Coupling of antibodies via protein Z on modified polyoma virus-like particles. Protein Sci. 2001, 10, 434-444.
14. Greenstone, H. L., Nieland, J. D., De Visser, K. E., Bruijn, M. L. H. et al., Chimeric papillomavirus virus-like-particles elicit antitumor immunity against the E7 oncoprotein in an HPV16 tumor model. Proc. Natl. Acad. Sci. USA 1998, 95, 1800-1805.
15. Jegerlehner, A., Storni, T., Lipowski, G., Schmid, M. et al., Regulation of IgG antibody responses by epitope density and CD21-mediated costimulation. Eur. J. Immunol. 2002, 32, 3305-3314.
16. Jegerlehner, A., Tissot, A., Lechner, F., Sebbel, P. et al., A molecular assembly system that renders antigens of choice highly repetitive for induction of protective B cell responses. Vaccine 2002, 20, 3104-3112.
17. Kratz, P. A., Boettcher, B., Nassal, M., Native display of complete foreign protein domains on the surface of hepatitis B virus capsids. Proc. Natl. Acad. Sci. USA 1999, 96, 1915-1920.
18. Reichel, C., Brinkman, M., Ruehland, C., Reiser, C. O. A., Hess, J., Heterologous virus-like-particles: recombinant nanosystems as versatile antigen delivery devices for immune intervention. Curr. Nanosci. 2006, 2, 295-309.
19. Sedlik, C., Saron, M., Sarraseca, J., Casal, I., Leclerc, C., Recombinant parvovirus-like particles as an antigen carrier: a novel nonreplicative exogenous antigen to elicit protective antiviral cytotoxic T cells. Proc. Natl. Acad. Sci. USA 1997, 94, 7503-7508.
20. Tegerstedt, K., Lindencrona, J. A., Curcio, C., Andreasson, K. et al., A single vaccination with polyomavirus VP1/VP2Her2 virus-like particles prevents outgrowth of HER-2/neu-expressing tumors. Cancer Res. 2005, 65, 5953-5957.
21. Gedvilaite, A., Froemmel, C., Sasnauskas, K., Micheel, B. et al., Formation of immunogenic virus-like-particles by inserting epitopes into surface-exposed regions of hamster polyomavirus major capsid protein. Virology 2000, 273, 21-35.
22. Murray, K., Shiau, A.-L., The core antigen of hepatitis B virus as a carrier for immunogenic peptides. Biol. Chem. 1999, 380, 277-283.
23. Chen, X. S., Stehle, T., Harrison, S. C., Interaction of polyomavirus internal protein VP2 with the major capsid protein VP1 and implications for participation of VP2 in viral entry. EMBO J. 1998, 17, 3233-3240.
24. Modis, Y., Trus, B. L., Harrison, S. C., Atomic model of the papillomavirus capsid. EMBO J. 2002, 21, 4754-4762.
25. Krauzewicz, N., Griffin, B. E., Polyoma and papilloma virus vectors for cancer gene therapy. Adv. Exp. Med. Biol. 2000, 465, 73-82.
26. Schmidt, U., Rudolph, R., Boehm, G., Mechanism of assembly of recombinant murine polyomavirus-like particles. J. Virol. 2000, 74, 1658-1662.
27. Goldmann, C., Stolte, N., Nisslein, T., Hunsmann, G. et al., Packaging of small molecules into VP1-virus-like particles of the human polyomavirus JC virus. J. Virol. Methods 2000, 90, 85-90.
28. Palkova, Z., Adamec, T., Liebl, D., Stokrova, J., Forstova, J., Production of polyomavirus structural protein VP1 in yeast cells and its interaction with cell structures. FEBS Lett. 2000, 478, 281-289.
29. Stehle, T., Yan, Y., Benjamin, T. L., Harrison, S. C., Structure of murine polyomavirus complexed with an oligosaccharide receptor fragment. Nature 1994. 369, 160-163.
30. Stehle, T., Harrison, S. C., Crystal structure of murine polyomavirus in complex with straight-chain and branched-chain sialyloligosaccharide receptor fragments. Structure 1996, 4, 183-194.
31. Stehle, T., Harrison, S. C., High-resolution structure of a polyomavirus VP1-oligosaccharide complex: implications for assembly and receptor binding. EMBO J. 1997, 16, 5139-5148.
32. Ruehland, C., Reichel, C., Neugebauer, M., Strich, S. et al., Immuno-Track®: The novel antibody-based technology for tracing in animal health, Biotechnol. J. 2006, 1, 625-632.
33. Raschke, A., Strich, S., Huppke, S., Neugebauer, M. et al., Induction and detection of long-lasting peptide-specific antibody responses in pigs and beef cattle: a powerful technology for tracing meat processing chains from stock farmers to sales counters. Food Control 2006, 17, 65-74.
34. Walders, B., Raschke, A., Neugebauer, M., Geuther, E. et al., Blending of a conventional Mycoplasma hyopneumoniae vaccine with a positive marker: tracking of immunised pigs by peptide-specific antibodies raised to the marker component. Res. Vet. Sci. 2005, 78, 135-141.
35. Sanger, F., Nicklen, S., Coulson, A. R., DNA sequencing with chainterminating inhibitors. Proc. Natl. Acad. Sci. USA 1977, 74, 5463-5467.
36. Emini, E. A., Hughes, J., Perlow, D., Boger, J., Induction of hepatitis A virus-neutralizing antibody by a virus-specific synthetic peptide. J. Virol. 1985, 55, 836-839.
37. Karplus, P. A., Schultz, G. E., Prediction of chain flexibility in proteins. Naturwissenschaften 1985, 72, 212-213.
38. Chou, P. Y., Fasman, G. D., Prediction of the secondary structure of proteins from their amino acid sequence. Adv. Enzymol. 1978, 47, 45-148.
39. Kyte, J., Doolittle, R. F., A simple method for displaying the hydropathic character of a protein. J. Mol. Biol. 1982, 157, 105-132.
40. Salunke, D. M., Caspar, D. L., Garcea, R. L., Polymorphism in the assembly of polyomavirus capsid protein VP1. Biophys. J. 1989, 56, 887-900.
41. U. S. Food and Drug Administration, Guideline on validation of the limulus amebocyte lysate test as an end-product endotoxin test for human and animal parental drugs, biological products and medical devices. Division of Manufacturing and Product Quality (HFN-320); Office of Compliance; Center for Drug Evaluation and Research, Food and Drug Administration, Rockville 1987.
42. Harris, J. R., Markl, J., Keyhole limpet hemocyanin (KLH): a biomedical review. Micron 1999, 30, 597-623.
43. Chackerian, B., Lenz, P., Lowy, D. R., Schiller, J. T., Determinants of autoantibody induction by conjugated papillomavirus virus-likeparticles. J. Immunol. 2002, 169, 6120-6126.
44. Szomolanyi-Tsuda, E., Le, Q. P., Garcea, R. L., Welsh, R. M., T cell-independent immunoglobulin G responses in vivo are elicited by virus-like infection but not by immunization with viral proteins or virus-like-particles. J. Virol. 1998, 72, 6665-6670.
45. Brown, A. L., Francis, M. J., Hastings, G. Z., Parry, N. R. et al., Foreign epitopes in immunodominant regions of hepatitis B core particles are highly immunogenic and conformationally restricted. Vaccine 1991, 9, 595-601
46. Fehr, E., Skrastina, D., Pumpens, P., Zinkernagel, R. M., T cell-independent type I antibody response against B cell epitopes expressed repetitively on recombinant virus particles. Proc. Natl. Acad. Sci. USA 1998, 95, 9477-9481.
47. Deml, L., Schirmbeck, R., Reimann, J., Wolf, H., Wagner, R., Purification and characterization of hepatitis B virus surface antigen particles produced in Drosophila Schneider-2 cells. J. Virol. Methods 1999, 79, 205-212.
48. Caparros-Wanderley, W., Clark, B., Griffin, B. E., Effect of dose and long-term storage on the immunogenicity of murine polyomavirus VP1 virus-like particles. Vaccine 2004, 22, 352-361.
49. Pirofski, L.-A., Casadevall, A., Use of licensed vaccines for active immunization of the immunocompromised host. Clin. Microbiol. Rev. 1998, 11, 1-26.